The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection

Antiviral Research

Volumn 113, Issue , 2015, Pages 1-3

  Weber, Christopher ^a   Sliva, Katja ^a   Von Rhein, Christine ^a   Kümmerer, Beate M ^b   Schnierle, Barbara S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Chikungunya virus; EGCG; Green tea

Indexed keywords

CATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; ANTIVIRUS AGENT; TEA;

ADENO ASSOCIATED VIRUS; AEDES ALBOPICTUS; ANTIVIRAL ACTIVITY; ARTICLE; CELL ADHESION; CHIKUNGUNYA; CONTROLLED STUDY; DEVELOPING COUNTRY; IN VITRO STUDY; NONHUMAN; TARGET CELL; TEA; UNITED STATES; VIRUS ATTACHMENT; VIRUS PARTICLE; ANALOGS AND DERIVATIVES; CHEMISTRY; CHIKUNGUNYA VIRUS; DRUG EFFECTS; GENE VECTOR; HEK293 CELL LINE; HUMAN; PHYSIOLOGY; VIRUS REPLICATION;

CHIKUNGUNYA VIRUS;

ANTIVIRAL AGENTS; CATECHIN; CHIKUNGUNYA VIRUS; GENETIC VECTORS; HEK293 CELLS; HUMANS; TEA; VIRUS ATTACHMENT; VIRUS REPLICATION;

EID: 84911895337     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.11.001     Document Type: Article

References (23)

1. W. Akahata, Z.-Y. Yang, H. Andersen, S. Sun, H.A. Holdaway, W.-P. Kong, M.G. Lewis, S. Higgs, M.G. Rossmann, S. Rao, and G.J. Nabel A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection Nat. Med. 16 3 2010 334 338
2. A. Bajak US assesses virus of the Caribbean Nature 512 7513 2014 124 125
3. F.W. Buaas, A.L. Kirsh, M. Sharma, D.J. McLean, J.L. Morris, M.D. Griswold, D.G. de Rooij, and R.E. Braun Plzf is required in adult male germ cells for stem cell self-renewal Nat. Genet. 36 6 2004 647 652
4. N. Calland, A. Albecka, S. Belouzard, C. Wychowski, G. Duverlie, V. Descamps, D. Hober, J. Dubuisson, Y. Rouille, and K. Seron (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry Hepatology 55 3 2012 720 729
5. C. Chen, H. Qiu, J. Gong, Q. Liu, H. Xiao, X.W. Chen, B.L. Sun, and R.G. Yang (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus Arch. Virol. 157 7 2012 1301 1312
6. S. Ciesek, H.T. von, C.C. Colpitts, L.M. Schang, M. Friesland, J. Steinmann, M.P. Manns, M. Ott, H. Wedemeyer, P. Meuleman, T. Pietschmann, and E. Steinmann The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry Hepatology 54 6 2011 1947 1955
7. C.C. Colpitts, and L.M. Schang A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans J. Virol. 88 14 2014 7806 7817 (0022-538X (Linking))
8. G. Fassina, A. Buffa, R. Benelli, O.E. Varnier, D.M. Noonan, and A. Albini Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent AIDS 16 6 2002 939 941
9. M. Kim, S.Y. Kim, H.W. Lee, J.S. Shin, P. Kim, Y.S. Jung, H.S. Jeong, J.K. Hyun, and C.K. Lee Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate Antiviral Res. 100 2 2013 460 472
10. N. Kishishita, N. Takeda, A. Anuegoonpipat, and S. Anantapreecha Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection J. Clin. Microbiol. 51 5 2013 1389 1395
11. B.M. Kuehn Chikungunya virus transmission found in the United States: US health authorities brace for wider spread JAMA 312 8 2014 776 777
12. B.M. Kümmerer, K. Grywna, S. Glasker, J. Wieseler, and C. Drosten Construction of an infectious chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites J. Gen. Virol. 93 Pt 9 2012 1991 1995
13. D.G. Nagle, D. Ferreira, and Y.D. Zhou Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives Phytochemistry 67 17 2006 1849 1855
14. Y.S. Ooi, K.M. Stiles, C.Y. Liu, G.M. Taylor, and M. Kielian Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry PLoS Pathog. 9 12 2013 e1003835
15. B. Salvador, Y. Zhou, A. Michault, M.O. Muench, and G. Simmons Characterization of chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein Virology 393 1 2009 33 41
16. J. Steinmann, J. Buer, T. Pietschmann, and E. Steinmann Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea Br. J. Pharmacol. 168 5 2013 1059 1073
17. A. Suhrbier, M.-C. Jaffar-Bandjee, and P. Gasque Arthritogenic alphaviruses[mdash]an overview Nat. Rev. Rheumatol. 8 7 2012 420 429
18. K.A. Tsetsarkin, D.L. Vanlandingham, C.E. McGee, and S. Higgs A single mutation in chikungunya virus affects vector specificity and epidemic potential PLoS Pathog. 3 12 2007 e201
19. J.E. Voss, M.-C. Vaney, S. Duquerroy, C. Vonrhein, C. Girard-Blanc, E. Crublet, A. Thompson, G. Bricogne, and F.A. Rey Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography Nature 468 7324 2010 709 712
20. S.C. Weaver, J.E. Osorio, J.A. Livengood, R. Chen, and D.T. Stinchcomb Chikungunya virus and prospects for a vaccine Expert Rev. Vaccines 11 9 2012 1087 1101
21. C. Weber, R. Konig, M. Niedrig, P. Emmerich, and B.S. Schnierle A neutralization assay for chikungunya virus infections in a multiplex format J. Virol. Methods 201 2014 7 12 (0166-0934 (Linking))
22. M.P. Williamson, T.G. McCormick, C.L. Nance, and W.T. Shearer Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy J. Allergy Clin. Immunol. 118 6 2006 1369 1374
23. K. Yamaguchi, M. Honda, H. Ikigai, Y. Hara, and T. Shimamura Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1) Antiviral Res. 53 1 2002 19 34